Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India
Raman Puri, Vimal Mehta, P. Barton Duell, Devaki Nair, Jagdish C. Mohan, Jamal Yusuf, Jamshed Dalal, Sundeep Mishra, Ravi R. Kasliwal, Rajeev Agarwal, Saibal Mukhopadhyay, Harsh Wardhan, Narendra Nath Khanna, Akshaya Pradhan, Rahul Mehrotra, Amit Kumar, Sonika Puri, A Muruganathan, G B Sattur, Madhur Yadav, Harinder Singh, Rajesh Agarwal, Rashmi Nanda
Topics & Concepts
MedicineFamilial hypercholesterolemiaMonoclonal antibodyPCSK9CholesterolAntibodyMonoclonalFocus (optics)LipoproteinStatement (logic)LDL receptorInternal medicinePharmacologyImmunologyPolitical sciencePhysicsLawOpticsLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism